Company news
Renalytix Plc (LSE:RENX) news
Renalytix Plc news releases on 6ix. Latest, Jul 8, 2019: FractalDx Positive Results Published in JASN
Press releases — page 6
FractalDx Positive Results Published in JASN
July 8, 2019
US CPT® Code Granted for KidneyIntelX(TM)
July 1, 2019
Positive results from FractalDx study published
June 7, 2019
KidneyIntelX commercial scale production milestone
June 4, 2019
CLIA Certificate Number issued for Renalytix Lab
May 28, 2019
Expansion of FractalDx core investigator group
May 21, 2019
University Medical Center Groningen collaboration
May 7, 2019
FDA grants Breakthrough Device designation
May 2, 2019
Publication of confirmation study results
April 1, 2019
RenalytixAI Forms Core Investigator Group
March 22, 2019
Investor briefing
March 12, 2019
Appointment of Nomad and Joint Broker
February 14, 2019
Joint venture partnership agreement with AKESOgen
February 13, 2019
RenalytixAI Expands Leadership Team
February 6, 2019
Initiates Clinical Validation Study
January 23, 2019
Clarification re. lock-up restrictions
January 21, 2019
Exercise of Option for Exclusive License
January 2, 2019
Planned appointment of joint broker & of NOMAD
December 20, 2018
Director Dealing
December 19, 2018
RENX Admission to AIM and First Day of Dealings
November 6, 2018